A drop of blood, a microscope and a screen you can watch. It is the most persuasive performance in alternative medicine, because the patient sees it happening. Almost everything being pointed at is either normal or an artifact of the slide.
The procedure is always the same. A finger is pricked, a drop of blood goes onto a slide, and the image appears on a monitor the patient can see. The practitioner narrates: this is your immune system struggling, these are the crystals of undigested protein, that is yeast, this stacking shows your blood is too acidic and too thick. Then comes the recommendation, and it is almost always something the same practitioner sells.
It is called live blood analysis, live cell analysis, nutritional blood analysis, fresh capillary blood analysis, or by the trade name of whatever system the clinic bought. The equipment is a darkfield or phase-contrast microscope with a camera, and it is entirely real. Hospital laboratories use darkfield microscopy for specific, narrow purposes. What is not real is the diagnostic system built on top of it.
Live blood analysis is not new and it is not a misapplication of modern haematology. It descends from a specific, identifiable idea that mainstream biology examined and discarded.
In 1925 the German zoologist Günther Enderlein published Bakterien-Cyklogenie, setting out a theory of pleomorphism: that microbes pass through multiple life stages, that they live within the blood of healthy people, and that disease occurs when they develop into pathogenic forms. On that account the blood is not sterile, and a practitioner who can see the small structures in it can read the patient's state of health directly.
Pleomorphism in that sense is not a fringe position within microbiology. It is a superseded one. The structures Enderlein described have been examined with tools he did not have, and in 2017 a study using electron microscopy, fluorescence staining and biochemical assays identified the bacteria-like forms seen in healthy human blood under darkfield as non-viable membrane vesicles — cellular debris, not organisms.
The technique reached the modern alternative market largely through American promoters, of whom the best known is the author of the pH Miracle books. He appears further down this page, in the section on convictions.
The single most common finding demonstrated to patients is rouleaux — red cells stacked like coins. Practitioners present it as evidence of acidity, poor oxygenation, dehydration, toxicity or "thick blood," and it photographs beautifully.
Rouleaux is a real phenomenon. It is also, on this kind of slide, largely a product of the slide itself. Blood begins to clot and stack the moment it contacts glass. Drying at the edges of the coverslip concentrates the cells and produces the effect. Examined near the centre of the coverslip, where the cells are still free-floating, rouleaux is rarely seen at all. The same drop of blood will therefore show dramatic pathology or nothing, depending on where the operator points the objective and how long the sample has been sitting.
| What the patient is told | What it actually is | Verdict |
|---|---|---|
| “Your blood is stacked — that's acidity and poor oxygen delivery.” | Rouleaux, largely an artifact of contact with glass, of drying at the coverslip edge, and of elapsed time. Not diagnostic of anything on a finger-stick sample viewed this way. | Artifact |
| “Those are bacteria, parasites or fungal forms living in your blood.” | The bacteria-like structures visible in healthy blood under darkfield were characterised in 2017 as non-viable membrane vesicles. Genuine bacteraemia and parasitaemia exist, are serious, and are diagnosed by culture and stained films in a laboratory, not by narration over a monitor. | Misidentified |
| “This shows candida or yeast overgrowth.” | Systemic candidiasis is a life-threatening condition of the profoundly immunocompromised, diagnosed by culture. It is not a common condition of otherwise well people, and it is not visible as a general finding on a finger-stick slide. | No basis |
| “Those crystals are undigested protein, or uric acid, or toxins.” | Debris and precipitate on an unfixed, unstained slide. There is no validated scheme mapping shapes on such a slide to dietary protein, toxic load or organ function. | Invented |
| “Your red cells are the wrong size — you're deficient.” | Fresh unstained cells measure roughly 1.3 µm larger than the dried, stained cells that haematology reference ranges were built from. Practitioners nonetheless compare fresh measurements against the laboratory range, which will make normal cells look enlarged. Iron and B12 status is established by blood tests that cost a fraction of the session. | Wrong yardstick |
| “We can see cancer, or the conditions that lead to it, early.” | Tested directly. In a prospective study, blood from 110 patients was examined by darkfield microscopy in the Enderlein manner; the method did not reliably detect cancer. There is no evidence it identifies malignancy or predicts it. | Tested, failed |
| “Come back in three months and we'll see the improvement.” | The commercial engine of the practice. Because the dominant findings are artifacts of preparation and timing, the follow-up slide can look better regardless of what the patient did. The improvement demonstrates the sample handling, not the supplement. | Unfalsifiable |
This is not a technique nobody has bothered to examine. Two questions have been put to it directly, and both were asked by researchers working within or sympathetic to complementary medicine rather than by hostile outsiders.
Two experienced darkfield specialists, with comparable training in Enderlein analysis, independently assessed 48 capillary blood samples from 24 patients in an inpatient internal medicine and geriatrics setting. Each was blind to the other. They recorded whether particular Enderlein structures were present.
Interobserver reliability came out at a kappa of 0.35, with a 95% confidence interval of 0.27 to 0.43. Test–retest reliability was 0.44, interval 0.36 to 0.53. The authors concluded that the analysis is very difficult to standardise and that the reliability of the test is low.
The claim that darkfield analysis detects cancer, or the conditions preceding it, at an early stage was tested prospectively in 110 patients, in the course of a study on iridology. It did not reliably detect cancer.
Beyond those two studies there is very little. A validity study on screening for iron and vitamin B12 deficiency describes its own scope as exploratory and notes there was no prior research on the question at all. There are no trials showing that live blood analysis changes what happens to a patient — no demonstration that acting on its findings improves any outcome, and none that it predicts anything.
It is worth noting who else has said so. Andrew Weil, one of the most prominent popularisers of integrative medicine in North America, has called darkfield live blood analysis old-fashioned hokum and told readers plainly not to buy into it. This is not a case of conventional medicine dismissing an outsider technique; people inside the alternative field say the same thing.
Elsewhere in this section we record that nobody has ever been penalised in Canada over the devices documented here. Live blood analysis is the exception to the pattern — not in Canada, but abroad, where courts have dealt with it repeatedly and severely.
| Who and where | When | Outcome |
|---|---|---|
| Errol Denton London, England |
March 2014 | Convicted at Westminster Magistrates' Court on nine counts under the Cancer Act 1939, which prohibits advertising an offer to treat or cure cancer. Prosecuted by Westminster City Council trading standards after complaints from the public. Fined the statutory maximum of £1,000 on each count, with £9,821 costs and a victim surcharge — a bill of just over £19,000. He practised from a rented room at a Harley Street address and ran a website offering a blood test using a powerful microscope. He appealed to the Crown Court in October 2014 and lost, the sentence being slightly reduced. |
| Stephen Ferguson London, England |
May 2014 | Convicted under the same Act, on seven counts, in a case brought by the same trading standards authority. Fined £1,750 with £2,500 costs. Prosecutions under the Cancer Act are rare; two in the same season, from the same office, is not a coincidence. |
| Errol Denton (again) London, England |
April 2018 | Convicted at Blackfriars Crown Court of two breaches of the Consumer Protection from Unfair Trading Regulations 2008 and one breach of the Food Safety Act 1990, following an investigation by National Trading Standards. Fined £2,250, ordered to pay £15,000 costs, and made subject to a Criminal Behaviour Order. The advertising regulator, which had told him to stop and been ignored, welcomed the outcome and stated that he had misled people into believing he was a doctor. |
| Robert O. Young California, USA |
1996, 2016, 2025 | Three criminal convictions in thirty years. A misdemeanour guilty plea in 1996 in Utah for practising medicine without a licence; felony convictions in 2016 over treating critically ill patients at his Valley Center ranch, for which he served just over five months under a plea agreement; and in February 2025 a jury convicted him again, on counts including wilful abuse of an elder, two counts of practising without a medical licence, and theft from an elder. In May 2025 he was sentenced to five years and eight months in state prison — four years for the elder abuse, one year for the theft, eight months for treating the sick without a licence. |
We searched for Canadian regulatory activity on live blood analysis in July 2026 — discipline decisions from the naturopathic, chiropractic and medical colleges, Health Canada advisories, Competition Bureau proceedings. We found none.
State the limits of that plainly, as we do everywhere on this site. It is a statement about what is published and indexed, searched on one date. Regulators resolve a great deal privately, and in several provinces only a fraction of outcomes are published at all. If a Canadian decision exists that we have missed, send it and we will print it. How that compares with the other four devices in this section is set out on Never for the device itself, and the answer is that the gap is in the same place every time.
What we can say is that the technique is not obscure here. It appears in Canadian clinic service lists, frequently alongside electrodermal screening — the two are natural companions, since both produce an impressive on-screen result in a single visit and both point toward a supplement protocol sold on the premises. The supply chain page documents how instruments of this kind reach Canadian practitioners.
The rest of this section is our opinion. Everything above it is sourced and checkable.
Compare the two columns. In England, a local council's trading standards office read a website, brought a prosecution under a 1939 statute, won on nine counts, won again on appeal, and when the defendant carried on, came back four years later and obtained a Criminal Behaviour Order. That is what a regulator looks like when it decides something matters. The total public cost was one investigating officer's time.
In Canada, so far as the published record shows, nobody has done anything at all. Not a college decision, not an advisory, not a Competition Bureau proceeding. And the Competition Act route is squarely available: a claim that a microscope image reveals yeast overgrowth or toxicity, made to sell a supplement protocol, is a performance claim, and the statute asks only whether it rests on adequate and proper testing. On the evidence set out above, the answer is that it does not.
We think the difference is not one of law. Both countries have the instruments. One country uses them.
What you were shown was almost certainly a normal slide. That is the good news and the bad news together: it means the alarming findings were probably not real, and it also means the reassuring ones tell you nothing.
If you were told you have an infection, a parasite, yeast overgrowth, or early signs of cancer, take that to a physician and ask for the actual test — a stained film, a culture, a blood count, whatever fits the symptom. Those tests exist, they are validated, and in Canada they are covered. If you were told your blood looked fine, that is not a reason to skip screening your doctor has recommended.
If you stopped or delayed a treatment because of what you saw on the screen, tell your physician that specifically. It is the single most useful thing you can say, and nobody will think less of you for it. This site cannot give medical advice and is not attempting to.
If you have seen this advertised, been offered a scan, or paid for one: four federal routes and one provincial route are open to you, with current contact details and an honest account of what each body can and cannot do, on How to complain, and to whom.
Origins and theory: Günther Enderlein, Bakterien-Cyklogenie (1925), and the pleomorphism concept it set out. The 2017 characterisation of darkfield-visible bacteria-like structures in healthy blood as non-viable membrane vesicles, using electron microscopy, fluorescence staining and biochemical assay.
Reliability: the pilot study of interobserver and test–retest reliability of Enderlein darkfield analysis — two blinded experienced observers, 48 capillary samples from 24 inpatients, interobserver kappa 0.35 (95% CI 0.27–0.43), test–retest kappa 0.44 (0.36–0.53), indexed on PubMed. Cancer detection: the prospective study of darkfield microscopy according to Enderlein in 110 patients, conducted alongside a study on iridology. Nutritional screening: the validity study of fresh capillary blood analysis by darkfield microscopy for iron and B12 deficiency, which records that no prior research on the question existed, and the associated finding on red cell diameter in fresh versus dried and stained samples.
Artifact: the analysis of rouleaux formation and coverslip position published by the Committee for Skeptical Inquiry. Commentary: Science-Based Medicine's account of the practice; Edzard Ernst's 2005 piece in The Guardian; Andrew Weil's published assessment.
Convictions: contemporaneous reporting and public records of the Westminster Magistrates' Court proceedings of March 2014 and the October 2014 Crown Court appeal; the May 2014 conviction of a second defendant under the same Act; the April 2018 Blackfriars Crown Court sentencing, together with the Advertising Standards Authority's published statement welcoming the fine and Criminal Behaviour Order; and San Diego County reporting of the 1996, 2016 and February 2025 convictions and the May 2025 sentencing, together with the 2018 civil verdict and its later reduction. The appellate citation for the civil matter is Kali v. Young, D076121 (Cal. Ct. App., 8 February 2021).
If you know of a Canadian discipline decision, advisory, order or proceeding concerning live blood analysis — from any college, any province, or any federal body — please send the citation. A correction that fills in an empty cell is the most useful thing anyone can send this page.